Article courtesy of Johns Hopkins Technology Ventures Barbara Slusher, Ph.D., M.A.S., director of Johns Hopkins Drug Discovery, and co-leader of the ICTR Drug, Biologics,…
Johns Hopkins University achieves 100% compliance with a federal law designed to reveal clinical trial results. By Patrick Smith The polio vaccine. Penicillin. Anesthesia.…
View Course Flyer October 25- December 10 The course — MEDI 502: Translational Science in the COVID-19 Pandemic – Accelerating and Enhancing our Response Across…
In his new role, Dr. Sulkowski will oversee activities related to clinical trials, focusing on commercial clinical trials. In addition, he will help develop an…
Post-acute Sequelae of COVID (PASC): Defining the Clinical Needs and Research Agenda REGISTER Please join us for an engaging town hall to discuss ongoing…
The Data Protection Attestation available here outlines expectations for the protection of patient data and serves as a data use agreement to enable the sharing of limited…
New Data Protection Attestation streamlines paperwork associated with sharing limited data sets for research among JHU researchers. The Data Protection Attestation available here outlines…
Mark Sulkowski, MD, Director of the COVID-19 Clinical Research Center named senior associate dean for clinical trials and the founding director of the Office of…
Open to all Johns Hopkins University Full-Time Faculty Members with an appointment of 5 years or fewer. The Clinical Research Scholars Program (KL2) is…
Cancer-fighting T cells from patients whose cancers responded to immunotherapy and from those whose tumors did not respond showed marked differences A tumor-specific T cell…
